Task: Answer the multiple choice question.
Question: Which drug exhibits a -0.530\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) CCOC(=O)c1c(C)c(C(=O)Nc2ccc3c(c2)OCO3)c(C)n1C
b.) CC(=O)Nc1ccc(OCC(O)CN2CCN(c3ccc(F)cc3)CC2)cc1
Answer: b. CC(=O)Nc1ccc(OCC(O)CN2CCN(c3ccc(F)cc3)CC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(=O)Nc1ccc(OCC(O)CN2CCN(c3ccc(F)cc3)CC2)cc1
CC(=O)Nc1ccc(OCC(O)CN2CCN(c3ccc(F)cc3)CC2)cc1
N-[4-[3-[4-(4-fluorophenyl)piperazin-1-yl]-2-hydroxypropoxy]phenyl]acetamide